(Q40896229)

English

Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

based on heuristic

inferred from title

Giampaolo Tortora

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

F Ciardiello

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

R Caputo

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

G Pomatico

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

M De Laurentiis

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

S De Placido

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A R Bianco

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

85

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

710-715

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Increased resistance to cytotoxic agents in ZR75B human breast cancer cells transfected with epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Epidermal growth factor receptor family and chemosensitization

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000301%2985%3A5%3C710%3A%3AAID-IJC18%3E3.0.CO%3B2-4

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(20000301)85:5<710::AID-IJC18>3.0.CO;2-4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40896229&oldid=1773989090"